explore -WSS

explore

author：entertainment 2025-10-01 02:15:01 - browse：81591

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Suspects arrested after 3 women attacked on Manhattan's West Side: Police

WSS

Prosecutors say FTX founder Sam Bankman

Novo pauses ads for weight loss drug Wegovy amid demand

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Xenotransplantation trials will require adjusting expectations, experts say

How to fix the rural physician shortage in the U.S.

hotspot

explore

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Cancer drug shortages should be causing more outrage

Reanimated hearts work just as well for transplants, study finds

Anesthesiologist group: stop taking Ozempic before surgery

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

DIEP, the 'gold standard' of breast reconstruction, is under threat

Bispecific antibodies are next new thing in cancer immunotherapy

Walensky prepares to leave CDC — and Congress — behind

Why the advice to take all your antibiotics may be wrong

entertainment

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Inside the rise of 'mukbang' eating videos

Reanimated hearts work just as well for transplants, study finds

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

explore

focus

focus

hotspot